Rising Gas Prices Weigh on Consumer Spending as Retail Sales Growth Slows Ken Griffin Warns Deeply Triggering Inflation Still Hurts Americans as Egg Prices Top 8 Per Dozen US Official Flags Japan as Part of FentanylSmuggling Route Air Products APD Aligns Industrial Gas Expansion with Rising Semiconductor Demand 5 Market Factors to Watch as Trading Opens Insights from Investopedia Bloomberg Opinion Argues for Fairer IPO Access for Retail Investors Milestone Pharmaceuticals MIST Q1 2026 Earnings Significant EPS Miss as PreRevenue Biotech Continues Pipeline Development GIGM Q3 2025 Earnings Narrowed Losses Amid Strategic Restructuring UPLD Q1 2026 Earnings EPS Surges Past Expectations Stock Reacts Positively SCCG Q4 2025 Earnings Significant EPS Beat Despite Stock Decline GREE Q1 2025 Earnings NarrowerthanExpected Loss Amid Crypto Headwinds Waste Connections Inc Q1 2026 Earnings EPS Beats Estimates Despite Flat Revenue Outlook John Hancock Income Securities Trust JHS Holds Steady at 1102 Amid RangeBound Trading Empery Digital Inc EMPD Retreats After Failed Upside Test Support at 472 in Focus Nuveen Quality Municipal Income Fund NAD Edges Higher Eyes Key Resistance Level Curis Inc CRIS Rallies on High Volume Testing Key Resistance at 053 Aehr Test Systems Surges 1577 Key Levels to Watch for Further Momentum Accenture Invests in AI Security Startup XBOW to Bolster Cyber Defense Capabilities MMS Q1 2026 Earnings EPS Beats Estimates Amid Cautious Market Response GigCapital7 Unit GIGGU Holds Steady at 994 as Market Digests SPAC Dynamics BHP Q1 2026 Earnings EPS Falls Short of Estimates Amid Commodity Headwinds Flowserve Q1 2026 Earnings EPS Beat Drives Modest Share Gains as Management Highlights Operational Execution PDLB Q4 2025 Earnings Significant EPS Beat Despite Modest Stock Decline LTRN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Control as RD Pipeline Advances GMAB Q1 2026 Earnings EPS Misses by Over 40 as Analyst Expectations Prove Too High Expion360 Q2 2025 Earnings EPS Beats Estimates by 307 Amid Cost Discipline Immunome Inc IMNM Q1 2026 Earnings SmallerThanExpected Loss as Biotech Advances Pipeline